Illumina To Acquire Grail Inc. For $7.1 Billion

The Wall Street Journal (9/21, Rockoff, Subscription Publication) reports Illumina will pay $7.1 billion to acquire Grail Inc., a developer of a liquid biopsy to detect cancer early. Reuters (9/21, Maddipatla, Spalding) reports that under the deal, Illumi...